Search

Search Constraints

You searched for: Author/Creator You, Pan

Search Results

4. Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients. Issue 10 (7th July 2014)

6. Elevated levels of mitochondrion‐associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer. Issue 8 (3rd January 2014)

7. Elevated levels of mitochondrion‐associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer. Issue 8 (3rd January 2014)